chromatograph mass spectrometer (GC/MS) with electron impact ionization. Although the samples were negative for drugs of abuse (benzodiazepines and opiates), by immunoassay, midazolam (benzodiazepine) was detected in putrefied material using GC/MS, thus indicating the hospitalization before death. 
Abstract
The objective of this work is to describe the type of biological samples submitted for toxicological analysis after exhumation. Forensic toxicologists receive a variety of biological samples, but exhumed biological specimens with varying degrees of putrefaction pose a greater challenge for analysis. Usually, immunoassay and colorimetric screening are the first line approach for toxicological analysis. Suitable samples can be selected for direct analysis using chromatographic techniques with a mass spectrometer, providing reliable results. The authors report two case studies where exhumed specimens were submitted for the determination of possible intoxication. The deceased were severely injured and remained hospitalized for more than 24 hours before death. Their corpses were exhumed for chemical analysis. For the toxicological analysis, selected samples were analyzed by immunoassay and a gas ‫من‬ ‫أفيونية)‬ ‫ال‬ ‫واملواد‬ ‫(البنزوديازيبينات‬ ‫املخدرات‬ ‫لتعاطي‬ ‫بالن�صبة‬ ‫(البنزوديازيبني)‬ ‫امليدازولم‬ ‫عن‬ ‫الك�صف‬ ‫مت‬ ‫املناعية‬ ‫الفحو�صات‬ ‫خالل‬ ‫إىل‬ ‫ا‬ ‫النتائج‬ ‫هذه‬ ‫وت�صري‬ ،GC/MS ‫تقنية‬ ‫با�صتخدام‬ ‫املتحللة‬ ‫العينات‬ ‫يف‬ ‫الوفاة.‬ ‫قبل‬ ‫امل�صت�صفى‬ ‫يف‬ ‫قدمت‬ ‫التي‬ ‫املعاجلة‬
Introduction
Forensic toxicologists receive variety of biological samples for toxicological analysis. Among these, exhumed biological specimens with varying degrees of putrefaction are common. Possible causes of putrefaction are enzymolysis, autolysis, and bacteriolysis [1] [2] . Usually, enzyme linked immunosorbent assay (ELISA), radio-immunoassay (RIA) [3] [4] , chromatographic techniques like thin-layer chromatography (TLC), high performance liquid chromatography (HPLC) [5] , and colorimetric tests are the first line approach of toxicological screening [6] . These analytical methods are validated for the analysis of fresh biological samples [7] [8] [9] , but exhumed specimens pose a problem of matrix interference. Owing to the unavailability of blood and urine samples after exhumation, a variety of putrefied biological tissues are submitted for toxicological analysis; the identification of tissues may not be ascertained. Selection of samples is very important as far as the pharmacology of drugs and poisons is concerned [10] . Suitable exhumed samples can be selected for direct analysis using chromatographic techniques with mass spectrometer, giving reliable results. Furthermore, availability of intoxication history (acute or chronic) can be helpful in selecting suitable samples.
This study aims to describe the toxicological analysis of exhumed biological samples by suitable analytical techniques. The authors have also evaluated the application of gas chromatography (GC) coupled with mass spectrometer (MS) in disentangling the problems faced in the toxicological analysis of exhumed biological specimens in the light of presented case studies.
Materials and Methods

Chemicals
Methanol, 1-chlorobutane, dichloromethane, sulfuric acid, zinc phosphide and N-Methyl-N-tert-butyldimethylsilyltrifluoroacetamide (MTBSTFA) were purchased from Sigma Aldrich, USA. Potassium cyanide, ammonium chloride, ammonium hydroxide, and sodium hydroxide were purchased from E. Merck, Germany. Desalkyl flurazepam, nordiazepam, diazepam, flunitrazepam, midazolam, bromazepam, oxazepam, chlordiazepoxide, temazepam, lorazepam, clonazepam, alprazolam, triazolam, α-OHAlprazolam, α-OH-Triazolam, amitriptyline, nortriptyline, promethazine, codeine, verapamil, oxycodone, chlorpheniramine, brompheniramine, doxepin, clomipramine, ketamine, venlafaxine, cyclobenzaprine, sertraline, fentanyl, haloperidol, imipramine, desipramine, chlorpromazine, trazodone, mepridine, phencyclidine, tramadol, mirtazepine, clozapine, metoprolol, paroxetine, and zolpidem were purchased from Cerilliant Corporation, USA. Synthetic negative blood, benzodiazepines and opiate ELISA kits were purchased from Immunalysis Corporation, Pomona, CA. De-ionized water was used in this work.
Sample Preparation
Confirmation for Benzodiazepines
For the confirmation of benzodiazepines using GC/MS, putrefied material was diluted and homogenized with distilled water. After the addition of 150 µL of desalkyl Flurazepam (methanolic solution of 2 µg/mL as internal standard) to a 2 mL homogenized sample (or spiked sample of drugs listed in Table- 1), 2 mL of ammonium chloride/ ammonium hydroxide buffer solution was added. Saturated aqueous solution of ammonium chloride adjusted to pH 9.2 with concentrated ammonium hydroxide was used as buffer solution. Samples were extracted with 5 mL of 1-chlorobutane. Back extraction of samples was performed in aqueous layer by using 2 M sulfuric acid (2 mL). Acidic aqueous layer was finally basified with ammonium hydroxide (500 µL) and re-extracted into 1-chlorobutane (5 mL). The organic layer was separated, dried under stream of nitrogen and derivatized with 50 µL of MTBSTFA.
Screening for basic drugs
For the extraction of basic drugs, homogenized putrefied material (2.0 mL) was sampled in a 15 mL polypropylene tube. After the addition of 50 µL of caffeine (methanolic solution of 100 µg/mL as internal standard), the sample (or spiked sample of basic drugs as in section 2.3) was basified with 0.1 M sodium hydroxide solution (1 mL) and extracted with 5 mL of 1-chlorobutane. Samples were then back extracted in aqueous layer by using 2.0 mL of 2 M sulfuric acid. Acidic aqueous layer was finally basified with ammonium hydroxide ‫العينات‬ ،GC/MS، GC/FID ‫القبور،‬ ‫نب�ش‬ ‫املفتاحية:‬ ‫الكلمات‬ ‫ال�صموم.‬ ‫علم‬ ‫حتديات‬ ‫املتحللة،‬ (500 µL) and re-extracted into 5 mL of dichloromethane. The organic layer was separated, dried under a stream of nitrogen and reconstituted with 50 µL of isopropanol.
Confirmation for poisonous gases
In order to confirm the presence of phosphine and cyanide in putrefied materials, about 1.0 mL of homogenized sample (or spiked sample of potassium cyanide and zinc phosphide) was added into a 20 mL clear glass headspace vial (Agilent Technologies, USA). The vial was quickly sealed after acidification with 5 mL of 10 M Sulfuric acid. The sample was analyzed by HS-GC/FID (7890A GC System, Agilent technologies, Palo Alto, CA) in a sequential analysis mode. Agilent GC Chemstation was used for the data analysis in external standard mode.
Instrument Conditions
Exhumed specimens were analyzed by using a Gas Chromatograph (7890A GC System, Agilent technologies, Palo Alto, CA) interfaced with a mass spectrometer (5973 quadruple Agilent technologies, Palo Alto, CA) and 7963 auto sampler. In addition, static head space (SHS) GC coupled with a flame ionization detector (FID) (Agilent technologies, Palo Alto, CA) was used for the confirmation of poisonous gases. Tables-1-3, describes the instrument conditions and analytical parameters used for the analysis. The selected samples were screened for the presence of drugs of abuse (benzodiazepines and opiates) using ELISA and confirmed by GCMS in SIM mode (Table-1) .
Basic drugs (amitriptyline, nortriptyline, promethazine, codeine, verapamil, oxycodone, chlorpheniramine, brompheniramine, doxepin, clomipramine, ketamine, venlafaxine, cyclobenzaprine, sertraline, fentanyl, haloperidol, imipramine, desipramine, chlorpromazine, trazodone, mepridine, phencyclidine, tramadol, mirtazepine, clozapine, metoprolol, diazepam, paroxetine, midazolam, zolpidem and alprazolam) were screened by GCMS (Table-2) after liquid-liquid extraction with organic solvents. Screening of poisonous gases (phosphine and cyanide) [11] was performed by colorimetric technique and later confirmed by GC/FID (Table-3 ) [12] on the same day in order to avoid gaseous loss from the sample, if any.
Case Reports
Case Report-1
A 30-year-old man was involved in a road traffic accident and was brought to the hospital for treatment. He 
Hydrogen flow 30 mL/min
Air flow 400 mL/min authors' laboratory. Putrefied material from the corpse was selected for toxicological examination.
Case Report-2
A 29-year-old male was shot and he died after 10-days of hospitalization. His body was buried without postmortem examination. The corpse was exhumed after eight months of burial for postmortem analysis, and the medicolegal officer requested a chemical examination of the specimen. The Authors' laboratory received a piece of coffin, some soil from the grave, putrefied material from the abdominal area, hair, nail, putrefied muscles, skin, ulna, radius and a control sample. Putrefied material from the abdominal area was subjected to toxicological examination.
Results and Discussion
Hair, nail, teeth and putrefied materials are the most commonly submitted exhumed samples in addition to soil samples [6] . Selection of soil samples is vital in the absence of hair and nail samples where suspicion of heavy metal poisoning cannot be overruled. Control soil samples are then used to rule out the natural presence of heavy metals in soil samples. Hair is the first choice for the detection of heavy metals (mercury, lead and arsenic etc.) and certain drugs along with their metabolites as they may accumulate in hair after chronic use [13] [14] . Quantitation of drugs is not possible in exhumed specimens because of the sample degradation, except in appropriately collected hair samples where section wise analysis provides reliable results [14] .
Sometimes, only the bony skeleton is available after exhumation. Gautam et al. have detected morphine, diazepam, ketamine, fentanyl, amitriptyline and olanzapine in bones [15] . Certain in-vitro studies have shown that most drugs can be detected both in blood and bone tissues, but there is a need to develop the correlation of drug concentrations in the tissue and the blood. In some cases however, drugs have been found only in bones but not in blood [15] , and the correlation of drug concentration in both tissues cannot be developed. There is still a need to do more work as very limited data is available regarding the concentration of drugs in bone [16] . As for drug analysis in buried human bones, authors were only able to find one study regarding the detection of morphine from the bone sample of a heroin addict [17] . Owing to the availability of very limited research on bones, detection of any drug in bone can only be corresponded as the evidence of exposure to that drug. Results of quantitation of drugs from bony tisdied after one day of hospitalization and was buried on the same day without postmortem analysis. Due to the suspicion of homicide, exhumation of the corpse was performed after 46-days of the burial. The corpse was at an advanced stage of putrefaction. After the postmortem examination, putrefied material, skin, tissue, hair and control samples of soil were collected and sent for chemical analysis to the Toxicological Analysis of Exhumed Specimens -A Challenge for Toxicologists sues can be compromised as there are multiple factors (collection method, extraction procedure, analytical techniques and storage conditions) that can produce variable results from the same sample. Further work is required to relate the blood levels of the drugs with the concentration in bone [16] .
In both of the case studies, the deceased were hospitalized after the injuries, providing the clue for the detection of certain drugs used during their treatment. No drug of abuse was detected when samples were screened with ELI-SA. In case study 1, laudanosine (metabolite of atracurium) and midazolam (benzodiazepine) were detected in putrefied material when screened with GCMS ( Figure-1) . The results were contrary to the findings of the ELISA screening where it was negative for the class of benzodiazepines.
In case study 2, putrefied material from the abdominal region was subjected to confirmation of benzodiazepines using GC/MS in SIM mode (Figure-2) . The specimen was confirmed to contain midazolam ( Figure-2 ) while the screening test was negative during ELISA procedure. The selected sample also tested false positive for the presence of phosphine and later found negative when confirmed by using GC/FID (Figure-3 ). In this case study, soil, hair and bone samples were not used due to the nature of injuries and death. The case corresponds to death after hospitalization and rules out the possibility of chronic heavy metal exposure as the cause of death. In both of the described cases, midazolam was detected by GCMS while it was not detected at the screening stage. Midazolam and atracurium were used during the surgical procedure of the hospitalized patients. Atracurium besylate injections are used for skeletal muscle relaxation during surgery [18] , and its metabolite (laudanosine) was detected in case study-1 as shown in Figure-1 .
Conclusion
Usually, after the negative immunoassay and colorimetric screening, confirmation procedure is not required. It is concluded from the study that common immunoassay and colorimetric techniques may not reveal the correct results of exhumed specimens owing to the matrix interferences. In such cases, extraction (liquid/liquid or solid phase) of the putrefied samples and screening by GC coupled with MS or FID detectors is a suitable choice for the detection of any analyte.
